Pharyngeal Carcinoma — Trials

Pharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 357
Recruiting: 191
Ph III recruiting: 58
Growth YoY: +6.7%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (85)

clinicaltrialsPublishedShowing 151–153 of 153 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00515957	Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)(DELLA)	withdrawn	Phase 1	0	Baylor College of MedicineOTHER	0	Apr 16, 2012	clinicaltrials
NCT00212108	A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839	completed	Phase 1 / Phase 2	22	National University Hospital, SingaporeOTHER	1	Apr 2, 2012	clinicaltrials